168 related articles for article (PubMed ID: 27457348)
1. Hepatocellular Carcinoma in Alcoholic Liver Disease: Current Management and Recent Advances.
Galati G; Dell'Unto C; Vespasiani-Gentilucci U; De Vincentis A; Gallo P; Guidi A; Picardi A
Rev Recent Clin Trials; 2016; 11(3):238-252. PubMed ID: 27457348
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
Reddy SK; Steel JL; Chen HW; DeMateo DJ; Cardinal J; Behari J; Humar A; Marsh JW; Geller DA; Tsung A
Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
[TBL] [Abstract][Full Text] [Related]
3. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].
Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387
[No Abstract] [Full Text] [Related]
4. Hepatocellular carcinoma in the setting of alcohol-related liver disease.
Ganne-Carrié N; Nahon P
J Hepatol; 2019 Feb; 70(2):284-293. PubMed ID: 30658729
[TBL] [Abstract][Full Text] [Related]
5. Pattern of macrovascular invasion in hepatocellular carcinoma.
Guarino M; Cucchetti A; Pontillo G; Farinati F; Benevento F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Rodolfo S; Cabibbo G; Marra F; Mega A; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Missale G; Masotto A; Nardone G; Raimondo G; Azzaroli F; Vidili G; Oliveri F; Trevisani F; Giannini EG; Morisco F;
Eur J Clin Invest; 2021 Jul; 51(7):e13542. PubMed ID: 33755196
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
Stickel F; Buch S; Nischalke HD; Weiss KH; Gotthardt D; Fischer J; Rosendahl J; Marot A; Elamly M; Casper M; Lammert F; McQuillin A; Zopf S; Spengler U; Marhenke S; Kirstein MM; Vogel A; Eyer F; von Felden J; Wege H; Buch T; Schafmayer C; Braun F; Deltenre P; Berg T; Morgan MY; Hampe J
Am J Gastroenterol; 2018 Oct; 113(10):1475-1483. PubMed ID: 29535416
[TBL] [Abstract][Full Text] [Related]
7. Advances in Management of Hepatocellular Carcinoma.
Intaraprasong P; Siramolpiwat S; Vilaichone RK
Asian Pac J Cancer Prev; 2016; 17(8):3697-703. PubMed ID: 27644603
[TBL] [Abstract][Full Text] [Related]
8. Fatty Liver Disease and Hepatocellular Carcinoma: The Pathologist's View.
Tiniakos DG; Maurício J; Reeves HL
Adv Exp Med Biol; 2018; 1032():55-69. PubMed ID: 30362090
[TBL] [Abstract][Full Text] [Related]
9. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
[TBL] [Abstract][Full Text] [Related]
10. Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma.
Kumar R; Goh BG; Kam JW; Chang PE; Tan CK
Clin Mol Hepatol; 2020 Apr; 26(2):196-208. PubMed ID: 31914720
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
Dongiovanni P; Romeo S; Valenti L
World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690
[TBL] [Abstract][Full Text] [Related]
12. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
Meringer H; Shibolet O; Deutsch L
World J Gastroenterol; 2019 Aug; 25(29):3929-3940. PubMed ID: 31413528
[TBL] [Abstract][Full Text] [Related]
14. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
Horie Y; Yamagishi Y; Ishii H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
[TBL] [Abstract][Full Text] [Related]
15. NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options.
Foerster F; Gairing SJ; Müller L; Galle PR
J Hepatol; 2022 Feb; 76(2):446-457. PubMed ID: 34555422
[TBL] [Abstract][Full Text] [Related]
16. The etiology of hepatocellular carcinoma and consequences for treatment.
Sanyal AJ; Yoon SK; Lencioni R
Oncologist; 2010; 15 Suppl 4():14-22. PubMed ID: 21115577
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiology, natural history, and risk factors of hepatocellular carcinoma].
Fares N; Péron JM
Rev Prat; 2013 Feb; 63(2):216-7, 220-2. PubMed ID: 23513788
[TBL] [Abstract][Full Text] [Related]
18. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?
Boye A; Zou YH; Yang Y
World J Gastroenterol; 2016 Jan; 22(1):50-71. PubMed ID: 26755860
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma.
Daoudaki M; Fouzas I
Wien Med Wochenschr; 2014 Nov; 164(21-22):450-5. PubMed ID: 25182146
[TBL] [Abstract][Full Text] [Related]
20. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U
J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
